ZLAB News and Press, Zai Lab Limited From 11/06/25

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

2025-11-05 14:01:15 ET More on Zai Lab Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in Clinical Development Transcript Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2025: Jefferies Global Healthcare Conference in London Fireside Chat: Wednesday, Novembe...

2025-10-27 01:49:32 ET Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Zoci and Outlines Next Steps in Clinical Development October 24, 2025 11:00 AM EDT... Read the full article on Seeking Alpha For further details see: Zai Lab Limited (ZLAB) Discusses...

2025-10-24 14:37:37 ET Zai Lab Limited (ZLAB) Discusses Updated Monotherapy Phase I Data for Suzhou and Outlines Next Steps in Clinical Development October 24, 2025 11:00 AM EDT... Read the full article on Seeking Alpha For further details see: Zai Lab Limited (ZLAB) Discuss...

- Robust responses observed in heavily pre-treated patients with a 68% ORR for 1.6 mg/kg in second-line setting -Compelling activity in patients with baseline brain metastases (n=32), including an 80% ORR for patients without prior brain radiotherapy - Duration of response of 6.1 ...

- Company to host conference call and webcast on November 6, 2025, at 8:00 a.m. ET (9:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its third quarter 2025 financial results and provide recent corporate updates on November 6, 2025, be...

- Oral presentation to feature new data highlighting the potential of zocilurtatug pelitecan (formerly called ZL-1310) as a promising next-generation, first- and best-in-class, Delta-like ligand (DLL3)-targeted antibody-drug conjugate (ADC) for patients with extensive-stage small cell lung cancer...

New York, New York--(Newsfile Corp. - September 10, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Zai Lab Limited ("Zai Lab Limited") (NASDAQ: ZLAB) concerning possible violations of federal securities laws. Zai Lab issued a press release on September ...

2025-09-09 18:47:49 ET Zai Lab Limited (ZLAB) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT... Read the full article on Seeking Alpha For further details see: Zai Lab Limited (ZLAB) Presents At Morgan Stanley 23rd Annual Global Healthc...